CVS Caremark gives FDA input on biogeneric approvals
In testimony for the Food and Drug Administration, a CVS Caremark Corp. executive reiterated the company’s support that the agency implement regulations needed to approve biogeneric drugs under the Patient Protection and Affordable Care Act.